Autoimmunity

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 129-152

  Cunha Neto, Edecio ^a,b   Teixeira, Priscila Camillo ^a,b   Nogueira, Luciana Gabriel ^a,b   Kalil, Jorge ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b São Paulo   (Brazil)

Author keywords

Antibodies; Autoimmunity; Chagas disease; Pathogenesis; T cells

Indexed keywords

ACTIN; AUTOANTIBODY; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR3; CHOLINERGIC RECEPTOR; CXCL9 CHEMOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DESMIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; MONOCLONAL ANTIBODY; MYOSIN; RIBOSOME DNA; RIBOSOME PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; BOOK; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; CHRONIC CHAGAS DISEASE CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DEMYELINATION; ELECTROCARDIOGRAPHY; GENE EXPRESSION PROFILING; HEART; HEART LEFT VENTRICLE FAILURE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFLAMMATION; LIVER; MICROSOME; MYOCARDITIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TRYPANOSOMA CRUZI;

ANIMALIA; TRYPANOSOMA CRUZI;

EID: 80052138373     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00006-2     Document Type: Chapter

References (158)

1. Abel L.C., Kalil J., Cunha Neto E. Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin. Braz. J. Med. Biol. Res. 1997, 30:1305-1308.
2. Abel L.C., Rizzo L.V., Ianni B., Albuquerque F., Bacal F., Carrara D., et al. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J. Autoimmun. 2001, 17:99-107.
3. Abel L.C., Iwai L.K., Viviani W., Bilate A.M., Fae K.C., Ferreira R.C., et al. T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein. Microbes Infect. 2005, 7:1184-1195.
4. Ablashi D.V., Lapps W., Kaplan M., Whitman J.E., Richert J.R., Pearson G.R. Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Mult. Scler. 1998, 4:490-496.
5. Acosta A.M., Santos-Buch C.A. Autoimmune myocarditis induced by Trypanosoma cruzi. Circulation 1985, 71:1255-1261.
6. Acosta A.M., Sadigursky M., Santos-Buch C.A. Anti-striated muscle antibody activity produced by Trypanosoma cruzi. Proc. Soc. Exp. Biol. Med. 1983, 172:364-369.
7. Aiello V.D., Reis M.M., Benvenuti L.A., Higuchi Mde L., Ramires J.A., Halperin J.A. A possible role for complement in the pathogenesis of chronic CCC. J. Pathol. 2002, 197:224-229.
8. Albareda M.C., Olivera G.C., Laucella S.A., Alvarez M.G., Fernandez E.R., Lococo B., et al. Chronic human infection with Trypanosoma cruzi drives CD4 T cells to immune senescence. J. Immunol. 2009, 183:4103-4108.
9. Al-Sabbagh A., Garcia C.A., Diaz-Bardales B.M., Zaccarias C., Sakurada J.K., Santos L.M. Evidence for cross-reactivity between antigen derived from Trypanosoma cruzi and myelin basic protein in experimental Chagas disease. Exp. Parasitol. 1998, 89:304-311.
10. Amorim D.D., Marin Neto J.A. Functional alterations of the autonomic nervous system in Chagas' heart disease. Sao Paulo Med. J. 1995, 113:772-784.
11. Anez N., Carrasco H., Parada H., Crisante G., Rojas A., Fuenmayor C., et al. Myocardial parasite persistence in chronic chagasic patients. Am. J. Trop. Med. Hyg. 1999, 60:726-732.
12. Araujo F.F., Gomes J.A., Rocha M.O., Williams-Blangero S., Pinheiro V.M., Morato M.J., et al. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front. Biosci. 2007, 12:2797-2806.
13. Bach-Elias M., Bahia D., Teixeira D.C., Cicarelli R.M. Presence of autoantibodies against small nuclear ribonucleoprotein epitopes in Chagas' patients' sera. Parasitol. Res. 1998, 84:796-799.
14. Barbosa A.A., Andrade Z.A. Identificação do Trypanosoma cruzi nos tecidos extracardíacos de portadores de miocardite crônica chagásica. Rev. Soc. Bras. Med. Trop. 1984, 17:123-126.
15. Bilate A.M., Salemi V.M., Ramires F.J., de Brito T., Silva A.M., Umezawa E.S., et al. The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis. Microbes Infect. 2003, 5:1116-1124.
16. Bocchi E.A., Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann. Thorac. Surg. 2001, 71:1833-1838.
17. Bonfa E., Viana V.S., Barreto A.C., Yoshinari N.H., Cossermelli W. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins. J. Immunol. 1993, 150:3917-3923.
18. Bonney K.M., Taylor J.M., Daniels M.D., Epting C.L., Engman D.M. Correction: heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity. PLoS One 2011, 6.
19. Borda E., Pascual J., Cossio P., De La Vega M., Arana R., Sterin-Borda L. A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity. Clin. Exp. Immunol. 1984, 57:679-686.
20. Britto C., Cardoso M.A., Ravel C., Santoro A., Pereira J.B., Coura J.R., et al. Trypanosoma cruzi: parasite detection and strain discrimination in chronic chagasic patients from northeastern Brazil using PCR amplification of kinetoplast DNA and nonradioactive hybridization. Exp. Parasitol. 1995, 81:462-471.
21. Caforio A.L., Grazzini M., Mann J.M., Keeling P.J., Bottazzo G.F., McKenna W.J., et al. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992, 85:1734-1742.
22. Camargo M.M., Almeida I.C., Pereira M.E., Ferguson M.A., Travassos L.R., Gazzinelli R.T. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 1997, 158:5890-5901.
23. Cetron M.S., Hoff R., Kahn S., Eisen H., Van Voorhis W.C. Evaluation of recombinant trypomastigote surface antigens of Trypanosoma cruzi in screening sera from a population in rural northeastern Brazil endemic for Chagas' disease. Acta Trop. 1992, 50:259-266.
24. Chambo J.G., Cabeza Meckert P.M., Laguens R.P. Presence of anti-Trypanosoma cruzi antibodies in the sera of mice with experimental autoimmune myocarditis. Experientia 1990, 46:977-979.
25. Cossio P.M., Diez C., Szarfman A., Kreutzer E., Candiolo B., Arana R.M. Chagasic cardiopathy. Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation 1974, 49:13-21.
26. Costa R.P., Gollob K.J., Fonseca L.L., Rocha M.O., Chaves A.C., Medrano-Mercado N., et al. T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand. J. Immunol. 2000, 51:511-519.
27. Cremaschi G., Zwirner N.W., Gorelik G., Malchiodi E.L., Chiaramonte M.G., Fossati C.A., et al. Modulation of cardiac physiology by an anti-Trypanosoma cruzi monoclonal antibody after interaction with myocardium. FASEB J. 1995, 9:1482-1488.
28. Cunha-Neto E., Moliterno R., Coelho V., Guilherme L., Bocchi E., Higuchi Mde L., et al. Restricted heterogeneity of T cell receptor variable alpha chain transcripts in hearts of Chagas' disease cardiomyopathy patients. Parasite Immunol. 1994, 16:171-179.
29. Cunha-Neto E., Duranti M., Gruber A., Zingales B., De Messias I., Stolf N., et al. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc. Natl. Acad. Sci. USA 1995, 92:3541-3545.
30. Cunha-Neto E., Coelho V., Guilherme L., Fiorelli A., Stolf N., Kalil J. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J. Clin. Invest. 1996, 98:1709-1712.
31. Cunha-Neto E., Abel L., Rizzo L.V., Goldberg A., Mady C., Ianni B., et al. Checkpoints for autoimmunity-induced heart tissue damage in human Chagas' disease. Mem. Inst. Oswaldo Cruz 1998, 93(Suppl. I):40-41.
32. Cunha-Neto E., Rizzo L.V., Albuquerque F., Abel L., Guilherme L., Bocchi E., et al. Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz. J. Med. Biol. Res. 1998, 31:133-137.
33. Cunha-Neto E., Dzau V.J., Allen P.D., Stamatiou D., Benvenutti L., Higuchi M.L., et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am. J. Pathol. 2005, 167:305-313.
34. Cunha-Neto E., Nogueira L.G., Teixeira P.C., Ramasawmy R., Drigo S.A., Goldberg A.C., et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem. Inst. Oswaldo Cruz 2009, 104(Suppl. 1):252-258.
35. Cunningham M.W., Antone S.M., Smart M., Liu R., Kosanke S. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect. Immun. 1997, 65:3913-3923.
36. de Araujo F.F., da Silveira A.B., Correa-Oliveira R., Chaves A.T., Adad S.J., Fiuza J.A., et al. Characterization of the presence of Foxp3(+) T cells from patients with different clinical forms of Chagas' disease. Hum. Pathol. 2011, 42:299-301.
37. de la Vega M.T., Damilano G., Diez C. Leukocyte migration inhibition test with heart antigens in American trypanosomiasis. J. Parasitol. 1976, 62:129-130.
38. de Oliveira S.F., Pedrosa R.C., Nascimento J.H., Campos de Carvalho A.C., Masuda M.O. Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation 1997, 96:2031-2037.
39. dos Santos R.R., Rossi M.A., Laus J.L., Silva J.S., Savino W., Mengel J. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J. Exp. Med. 1992, 175:29-39.
40. Drigo S.A., Cunha-Neto E., Ianni B., Cardoso M.R., Braga P.E., Fae K.C., et al. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect. 2006, 8:598-603.
41. Elias F.E., Vigliano C.A., Laguens R.P., Levin M.J., Berek C. Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease. Am. J. Trop. Med. Hyg. 2003, 68:242-247.
42. el-Zayadi A.R., Selim O.E., Hamdy H., Dabbous H., Ahdy A., Moniem S.A. Association of chronic hepatitis C infection and diabetes mellitus. Trop. Gastroenterol. 1998, 19:141-144.
43. Ferrari I., Levin M.J., Wallukat G., Elies R., Lebesgue D., Chiale P., et al. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J. Exp. Med. 1995, 182:59-65.
44. Ferreira R.C., Ianni B.M., Abel L.C., Buck P., Mady C., Kalil J., et al. Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem. Inst. Oswaldo Cruz 2003, 98:407-411.
45. Fonseca S.G., Moins-Teisserenc H., Clave E., Ianni B., Nunes V.L., Mady C., et al. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect. 2005, 7:688-697.
46. Fonseca S.G., Reis M.M., Coelho V., Nogueira L.G., Monteiro S.M., Mairena E.C., et al. Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy. Scand. J. Immunol. 2007, 66:362-371.
47. Gattass C.R., Lima M.T., Nobrega A.F., Barcinski M.A., Dos Reis G.A. Do self-heart-reactive T cells expand in Trypanosoma cruzi-immune hosts?. Infect. Immun. 1988, 56:1402-1405.
48. Gea S., Ordonez P., Cerban F., Iosa D., Chizzolini C., Vottero-Cima E. Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies. Am. J. Trop. Med. Hyg. 1993, 49:581-588.
49. Giordanengo L., Fretes R., Diaz H., Cano R., Bacile A., Vottero-Cima E., et al. Cruzipain induces autoimmune response against skeletal muscle and tissue damage in mice. Muscle Nerve 2000, 23:1407-1413.
50. Giordanengo L., Maldonado C., Rivarola H.W., Iosa D., Girones N., Fresno M., et al. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. Eur. J. Immunol. 2000, 30:3181-3189.
51. Giordanengo L., Gea S., Barbieri G., Rabinovich G.A. Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease. Clin. Exp. Immunol. 2001, 124:266-273.
52. Giordanengo L., Guinazu N., Stempin C., Fretes R., Cerban F., Gea S. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 2002, 32:1003-1011.
53. Girones N., Rodriguez C.I., Basso B., Bellon J.M., Resino S., Munoz-Fernandez M.A., et al. Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease. Clin. Diagn. Lab. Immunol. 2001, 8:1039-1043.
54. Girones N., Rodriguez C.I., Carrasco-Marin E., Hernaez R.F., de Rego J.L., Fresno M. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease. J. Clin. Invest. 2001, 107:985-993.
55. Goin J.C., Borda E., Segovia A., Sterin-Borda L. Distribution of antibodies against beta-adrenoceptors in the course of human Trypanosoma cruzi infection. Proc. Soc. Exp. Biol. Med. 1991, 197:186-192.
56. Goin J.C., Borda E., Leiros C.P., Storino R., Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J. Auton. Nerv. Syst. 1994, 47:45-52.
57. Goin J.C., Leiros C.P., Borda E., Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J. 1997, 11:77-83.
58. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 2003, 71:1185-1193.
59. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Busek S.C., Teixeira M.M., Silva J.S., et al. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect. Immun. 2005, 73:7960-7966.
60. Gruber A., Zingales B. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease. Exp. Parasitol. 1993, 76:1-12.
61. Harrington W.F., Rodgers M.E. Myosin. Annu. Rev. Biochem. 1984, 53:35-73.
62. Heber-Katz E., Acha-Orbea H. The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. Immunol. Today 1989, 10:164-169.
63. Hernandez C.C., Barcellos L.C., Gimenez L.E., Cabarcas R.A., Garcia S., Pedrosa R.C., et al. Human chagasic IgGs bind to cardiac muscarinic receptors and impair L-type Ca2+ currents. Cardiovasc. Res. 2003, 58:55-65.
64. Hernandez-Munain C., De Diego J.L., Alcina A., Fresno M. A Trypanosoma cruzi membrane protein shares an epitope with a lymphocyte activation antigen and induces crossreactive antibodies. J. Exp. Med. 1992, 175:1473-1482.
65. Higuchi Mde L., Gutierrez P.S., Aiello V.D., Palomino S., Bocchi E., Kalil J., et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch. A Pathol. Anat. Histopathol. 1993, 423:157-160.
66. Higuchi M.L., De Morais C.F., Pereira Barreto A.C., Lopes E.A., Stolf N., Bellotti G., et al. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin. Cardiol. 1987, 10:665-670.
67. Higuchi M.D., Ries M.M., Aiello V.D., Benvenuti L.A., Gutierrez P.S., Bellotti G., et al. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am. J. Trop. Med. Hyg. 1997, 56:485-489.
68. Hontebeyrie-Joskowicz M., Said G., Milon G., Marchal G., Eisen H. L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease. Eur. J. Immunol. 1987, 17:1027-1033.
69. Iwai L.K., Duranti M.A., Abel L.C., Juliano M.A., Kalil J., Juliano L., et al. Retro-inverso peptide analogues of Trypanosoma cruzi B13 protein epitopes fail to be recognized by human sera and peripheral blood mononuclear cells. Peptides 2001, 22:853-860.
70. Iwai L.K., Juliano M.A., Juliano L., Kalil J., Cunha-Neto E. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J. Autoimmun. 2005, 24:111-117.
71. Jones E.M., Colley D.G., Tostes S., Lopes E.R., Vnencak-Jones C.L., McCurley T.L. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human CCC. Am. J. Trop. Med. Hyg. 1993, 48:348-357.
72. Kalil J., Cunha-Neto E. Autoimmunity in chagas disease cardiomyopathy: fulfilling the criteria at last?. Parasitol. Today 1996, 12:396-399.
73. Kaplan D., Ferrari I., Bergami P.L., Mahler E., Levitus G., Chiale P., et al. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 1997, 94:10301-10306.
74. Kerner N., Liegeard P., Levin M.J., Hontebeyrie-Joskowicz M. Trypanosoma cruzi: antibodies to a MAP-like protein in chronic Chagas' disease cross-react with mammalian cytoskeleton. Exp. Parasitol. 1991, 73:451-459.
75. Khoury E.L., Diez C., Cossio P.M., Arana R.M. Heterophil nature of EVI antibody in Trypanosoma cruzi infection. Clin. Immunol. Immunopathol. 1983, 27:283-288.
76. Koberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 1968, 6:63-116.
77. Laguens R.P., Meckert P.C., Chambo G., Gelpi R.J. Chronic Chagas disease in the mouse. II. Transfer of the heart disease by means of immunocompetent cells. Medicina (B Aires) 1981, 41:40-43.
78. Laucella S.A., de Titto E.H., Segura E.L. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease. Acta Trop. 1996, 62:151-162.
79. Laucella S.A., Velazquez E., Dasso M., de Titto E. Trypanosoma cruzi and mammalian heart cross-reactive antigens. Acta Trop. 1996, 61:223-238.
80. Leiros C.P., Sterin-Borda L., Borda E.S., Goin J.C., Hosey M.M. Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J. Biol. Chem. 1997, 272:12989-12993.
81. Leon J.S., Godsel L.M., Wang K., Engman D.M. Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect. Immun. 2001, 69:5643-5649.
82. Leon J.S., Wang K., Engman D.M. Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease. J. Immunol. 2003, 171:4271-4277.
83. Leon J.S., Daniels M.D., Toriello K.M., Wang K., Engman D.M. A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect. Immun. 2004, 72:3410-3417.
84. Levin M.J., Mesri E., Benarous R., Levitus G., Schijman A., Levy-Yeyati P., et al. Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease. Am. J. Trop. Med. Hyg. 1989, 41:530-538.
85. Levitus G., Hontebeyrie-Joskowicz M., Van Regenmortel M.H., Levin M.J. Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin. Exp. Immunol. 1991, 85:413-417.
86. Liao L., Sindhwani R., Leinwand L., Diamond B., Factor S. Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes. J. Clin. Invest. 1993, 92:2877-2882.
87. Lopez Bergami P., Cabeza Meckert P., Kaplan D., Levitus G., Elias F., Quintana F., et al. Immunization with recombinant Trypanosoma cruzi ribosomal P2beta protein induces changes in the electrocardiogram of immunized mice. FEMS Immunol. Med. Microbiol. 1997, 18:75-85.
88. Lopez Bergami P., Scaglione J., Levin M.J. Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J. 2001, 15:2602-2612.
89. Mady C., Cardoso R.H., Barretto A.C., da Luz P.L., Bellotti G., Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994, 90:3098-3102.
90. Mahler E., Sepulveda P., Jeannequin O., Liegeard P., Gounon P., Wallukat G., et al. A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor. Eur. J. Immunol. 2001, 31:2210-2216.
91. Marinho C.R., D'Imperio Lima M.R., Grisotto M.G., Alvarez J.M. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect. Immun. 1999, 67:308-318.
92. Martin U.O., Afchain D., de Marteleur A., Ledesma O., Capron A. Circulating immune complexes in different developmental stages of Chagas' disease. Medicina (B Aires) 1987, 47:159-162.
93. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 1998, 19:395-404.
94. Masuda M.O., Levin M., De Oliveira S.F., Dos Santos Costa P.C., Bergami P.L., Dos Santos Almeida N.A., et al. Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J. 1998, 12:1551-1558.
95. McCormick T.S., Rowland E.C. Trypanosoma cruzi: cross-reactive anti-heart autoantibodies produced during infection in mice. Exp. Parasitol. 1989, 69:393-401.
96. Mengel J., Ribeiro-dos-Santos R. Autoreactive CD4+ T cells in the pathogenesis of chronic myocarditis found in experimental Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 1998, 93(Suppl. I):28-29.
97. Mijares A., Verdot L., Peineau N., Vray B., Hoebeke J., Argibay J. Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes. Mol. Cell. Biochem. 1996, 163-164:107-112.
98. Milei J., Storino R., Fernandez Alonso G., Beigelman R., Vanzulli S., Ferrans V.J. Endomyocardial biopsies in chronic CCC. Immunohistochemical and ultrastructural findings. Cardiology 1992, 80:424-437.
99. Minoprio P. Parasite polyclonal activators: new targets for vaccination approaches?. Int. J. Parasitol. 2001, 31:588-591.
100. Minoprio P., Burlen O., Pereira P., Guilbert B., Andrade L., Hontebeyrie-Joskowicz M., et al. Most B cells in acute Trypanosoma cruzi infection lack parasite specificity. Scand. J. Immunol. 1988, 28:553-561.
101. Motran C.C., Cerban F.M., Rivarola W., Iosa D., Vottero de Cima E. Trypanosoma cruzi: immune response and functional heart damage induced in mice by the main linear B-cell epitope of parasite ribosomal P proteins. Exp. Parasitol. 1998, 88:223-230.
102. Neu N., Craig S.W., Rose N.R., Alvarez F., Beisel K.W. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin. Exp. Immunol. 1987, 69:566-574.
103. Neu N., Rose N.R., Beisel K.W., Herskowitz A., Gurri-Glass G., Craig S.W. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 1987, 139:3630-3636.
104. Neu N., Ploier B., Ofner C. Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J. Immunol. 1990, 145:4094-4100.
105. Olivares-Villagomez D., McCurley T.L., Vnencak-Jones C.L., Correa-Oliveira R., Colley D.G., Carter C.E. Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue. Am. J. Trop. Med. Hyg. 1998, 59:563-570.
106. Oliveira M.F., Bijovsky A.T., Carvalho T.U., de Souza W., Alves M.J., Colli W. A monoclonal antibody to Trypanosoma cruzi trypomastigotes recognizes a myosin tail epitope. Parasitol. Res. 2001, 87:1043-1049.
107. Oliveira E.C., Fujisawa M.M., Hallal Longo D.E., Farias A.S., Contin Moraes J., Guariento M.E., et al. Neuropathy of gastrointestinal Chagas' disease: immune response to myelin antigens. Neuroimmunomodulation 2009, 16:54-62.
108. Palomino S.A., Aiello V.D., Higuchi M.L. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann. Trop. Med. Parasitol. 2000, 94:571-579.
109. Pereira J.B., Wilcox H.P., Coura J.R. The evolution of chronic chagasic cardiopathy. I. The influence of parasitemia. Rev. Soc. Bras. Med. Trop. 1992, 25:101-108.
110. Petry K., Eisen H. Chemical characterization of epitopes common to Trypanosoma cruzi and mammalian nervous cells. Mem. Inst. Oswaldo Cruz 1988, 83(Suppl. 1):498-501.
111. Petry K., Eisen H. Chagas disease: a model for the study of autoimmune diseases. Parasitol. Today 1989, 5:111-116.
112. Petry K., Voisin P., Baltz T. Complex lipids as common antigens to Trypanosoma cruzi, T. dionisii, T. vespertilionis and nervous tissue (astrocytes, neurons). Acta Trop. 1987, 44:381-386.
113. Petry K., Voisin P., Baltz T., Labouesse J. Epitopes common to trypanosomes (T. cruzi, T. dionisii and T. vespertilionis (Schizotrypanum)): astrocytes and neurons. J. Neuroimmunol. 1987, 16:237-252.
114. Petry K., Nudelman E., Eisen H., Hakomori S. Sulfated lipids represent common antigens on the surface of Trypanosoma cruzi and mammalian tissues. Mol. Biochem. Parasitol. 1988, 30:113-121.
115. Pontes-de-Carvalho L., Santana C.C., Soares M.B., Oliveira G.G., Cunha-Neto E., Ribeiro-dos-Santos R. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J. Autoimmun. 2002, 18:131-138.
116. Ramasawmy R., Cunha-Neto E., Fae K.C., Martello F.G., Muller N.G., Cavalcanti V.L., et al. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin. Infect. Dis. 2006, 43:305-311.
117. Ramasawmy R., Cunha-Neto E., Fae K.C., Muller N.G., Cavalcanti V.L., Drigo S.A., et al. BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J. Infect. Dis. 2006, 193:1394-1399.
118. Ramasawmy R., Spina G.S., Fae K.C., Pereira A.C., Nisihara R., Messias Reason I.J., et al. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin. Vaccine Immunol. 2008, 15:932-936.
119. Ramasawmy R., Cunha-Neto E., Fae K.C., Borba S.C., Teixeira P.C., Ferreira S.C., et al. Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J. Infect. Dis. 2009, 199:1838-1845.
120. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Gazzinelli G., Colley D.G., et al. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 1993, 48:637-644.
121. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Chapadeiro E., Gazzinelli G., et al. Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am. J. Trop. Med. Hyg. 1993, 49:192-200.
122. Reis M.M., Higuchi Mde L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., et al. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin. Immunol. Immunopathol. 1997, 83:165-172.
123. Riarte A., Luna C., Sabatiello R., Sinagra A., Schiavelli R., De Rissio A., et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin. Infect. Dis. 1999, 29:561-567.
124. Ribeirao M., Pereira-Chioccola V.L., Renia L., Augusto Fragata Filho A., Schenkman S., Rodrigues M.M. Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol. 2000, 22:49-53.
125. Ribeiro dos Santos R., Marquez J.O., Von Gal Furtado C.C., Ramos de Oliveira J.C., Martins A.R., Koberle F. Antibodies against neurons in chronic Chagas' disease. Tropenmed. Parasitol. 1979, 30:19-23.
126. Ribeiro A.L., Gimenez L.E., Hernandez C.C., de Carvalho A.C., Teixeira M.M., Guedes V.C., et al. Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int. J. Cardiol. 2007, 117:59-63.
127. Ribeiro C.H., Lopez N.C., Ramirez G.A., Valck C.E., Molina M.C., Aguilar L., et al. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Mol. Immunol. 2009, 46:1092-1099.
128. Ribeiro-Dos-Santos R., Mengel J.O., Postol E., Soares R.A., Ferreira-Fernandez E., Soares M.B., et al. A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol. 2001, 23:93-101.
129. Rizzo L.V., Cunha-Neto E., Teixeira A.R. Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect. Immun. 1989, 57:2640-2644.
130. Rose N.R., Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today 1993, 14:426-430.
131. Ruiz A.M., Esteva M., Cabeza Meckert P., Laguens R.P., Segura E.L. Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi. Acta Trop. 1985, 42:299-309.
132. Santos-Buch C.A., Teixeira A.R. The immunology of experimental Chagas' disease. 3. Rejection of allogeneic heart cells in vitro. J. Exp. Med. 1974, 140:38-53.
133. Santos-Buch C.A., Acosta A.M., Zweerink H.J., Sadigursky M., Andersen O.F., von Kreuter B.F., et al. Primary muscle disease: definition of a 25-kDa polypeptide myopathic specific chagas antigen. Clin. Immunol. Immunopathol. 1985, 37:334-350.
134. Sartori A.M., Shikanai-Yasuda M.A., Amato Neto V., Lopes M.H. Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease causing cardiac disease in three patients. Clin. Infect. Dis. 1998, 26:177-179.
135. Silva-Barbosa S.D., Cotta-de-Almeida V., Riederer I., De Meis J., Dardenne M., Bonomo A., et al. Involvement of laminin and its receptor in abrogation of heart graft rejection by autoreactive T cells from Trypanosoma cruzi-infected mice. J. Immunol. 1997, 159:997-1003.
136. Smith S.C., Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 1991, 147:2141-2147.
137. Smith S.C., Allen P.M. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc. Natl. Acad. Sci. USA 1992, 89:9131-9135.
138. Snary D., Flint J.E., Wood J.N., Scott M.T., Chapman M.D., Dodd J., et al. A monoclonal antibody with specificity for Trypanosoma cruzi, central and peripheral neurones and glia. Clin. Exp. Immunol. 1983, 54:617-624.
139. Sterin-Borda L., Gorelik G., Borda E.S. Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals. Clin. Immunol. Immunopathol. 1991, 61:387-397.
140. Sterin-Borda L., Goin J.C., Bilder C.R., Iantorno G., Hernando A.C., Borda E. Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut 2001, 49:699-705.
141. Talvani A., Rocha M.O., Barcelos L.S., Gomes Y.M., Ribeiro A.L., Teixeira M.M. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in CCC. Clin. Infect. Dis. 2004, 38:943-950.
142. Tarleton R.L., Zhang L., Downs M.O. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. USA 1997, 94:3932-3937.
143. Teixeira A.R., Santos-Buch C.A. The immunology of experimental Chagas' disease. II. Delayed hypersensitivity to Trypanosoma cruzi antigens. Immunology 1975, 28:401-410.
144. Teixeira A.R., Teixeira G., Macedo V., Prata A. Trypanosoma cruzi-sensitized T-lymphocyte mediated 51CR release from human heart cells in Chagas' disease. Am. J. Trop. Med. Hyg. 1978, 27:1097-1107.
145. Ternynck T., Bleux C., Gregoire J., Avrameas S., Kanellopoulos-Langevin C. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies. J. Immunol. 1990, 144:1504-1511.
146. Tibbetts R.S., McCormick T.S., Rowland E.C., Miller S.D., Engman D.M. Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. J. Immunol. 1994, 152:1493-1499.
147. Torres C.M. Patologia de la miocarditis cronica en la enfermedad de Chagas 1929, 902-916.
148. Van Voorhis W.C., Eisen H. Fl-160-A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J. Exp. Med. 1989, 169:641-652.
149. Van Voorhis W.C., Schlekewy L., Trong H.L. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc. Natl. Acad. Sci. USA 1991, 88:5993-5997.
150. Van Voorhis W.C., Barrett L., Koelling R., Farr A.G. FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues. J. Exp. Med. 1993, 178:681-694.
151. Vashishtha A., Fischetti V.A. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J. Immunol. 1993, 150:4693-4701.
152. Vazquez M.C., Riarte A., Pattin M., Lauricella M. Chagas' disease can be transmitted through kidney transplantation. Transplant. Proc. 1993, 25:3259-3260.
153. Vazquez M.C., Sabbatiello R., Schiavelli R., Maiolo E., Jacob N., Pattin M., et al. Chagas disease and transplantation. Transplant. Proc. 1996, 28:3301-3303.
154. Vermelho A.B., de Meirelles Mde N., Pereira M.C., Pohlentz G., Barreto-Bergter E. Heart muscle cells share common neutral glycosphingolipids with Trypanosoma cruzi. Acta Trop. 1997, 64:131-143.
155. Wallukat G., Munoz Saravia S.G., Haberland A., Bartel S., Araujo R., Valda G., et al. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. J. Am. Coll. Cardiol. 2011, 55:463-468.
156. Wood J.N., Hudson L., Jessell T.M., Yamamoto M. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites. Nature 1982, 296:34-38.
157. Zicker F., Smith P.G., Netto J.C., Oliveira R.M., Zicker E.M. Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy. Am. J. Trop. Med. Hyg. 1990, 43:498-505.
158. Zwirner N.W., Malchiodi E.L., Chiaramonte M.G., Fossati C.A. A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease. Infect. Immun. 1994, 62:2483-2489.